Twist Bioscience Corp (TWST) reports a record $99 million in Q4 revenue, with significant growth in AI-enabled drug discovery and plans for new product launches in 2026.

Sensus Healthcare, Inc. , a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, ...

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...

Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most ...

This update expands access to next-generation proteomics by enabling more labs to generate reliable, high-quality protein data through a simple NGS-based workflow. Even more researchers can explore ...

Melanoma is the deadliest form of skin cancer, responsible for thousands of deaths each year; but early detection can ...

On World Diabetes Day, Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug ...

Malhotra says that cancer cells “need a lot of glucose” to grow and that “ENO1 plays an extremely important role providing ...